Drugs that contain Ertapenem Sodium

1. Invanz patent expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US5652233 MSD SUB MERCK Antibiotic compounds
Feb, 2013

(11 years ago)

US7342005 MSD SUB MERCK Antibiotic compounds
Feb, 2013

(11 years ago)

US5652233

(Pediatric)

MSD SUB MERCK Antibiotic compounds
Aug, 2013

(10 years ago)

US7342005

(Pediatric)

MSD SUB MERCK Antibiotic compounds
Aug, 2013

(10 years ago)

US5478820 MSD SUB MERCK Antibiotic compounds
Nov, 2015

(8 years ago)

US5478820

(Pediatric)

MSD SUB MERCK Antibiotic compounds
May, 2016

(8 years ago)

US5952323 MSD SUB MERCK Carbapenem antibiotic
May, 2017

(7 years ago)

US5952323

(Pediatric)

MSD SUB MERCK Carbapenem antibiotic
Nov, 2017

(6 years ago)




Market Authorisation Date: 21 November, 2001

Treatment: Treatment of bacterial infectious disease

Dosage: INJECTABLE

How can I launch a generic of INVANZ before it's drug patent expiration?
More Information on Dosage

INVANZ family patents

Family Patents